Flex stock surges 75% in a year, fueled by data center expansion, strategic buys and broad advanced manufacturing strength.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Oracle has named Clay Magouyrk and Mike Sicilia as CEOs, with current CEO Safra Catz becoming executive vice chair of the technology company's board.

Landmark Bancorp (LARK) delivered strong Q2 results, with net interest income up 25% and well-covered dividends, despite higher loan loss provisions. LARK maintains a healthy liquidity profile, with a balanced loan book and a focus on both residential and commercial real estate lending. While non-accruals rose, most problem loans are collateralized or being resolved, and loan loss allowances appear sufficient for current risks.

Airbus continues strong stock performance, but the delivery profile remains a challenge. August 2025 saw 99 orders, mainly from Avolon, with no cancellations and a net order value of $7.4 billion, up year-over-year. Airbus delivered 61 jets in August, showing year-over-year improvement, but faces a steep ramp-up to meet its 820 annual delivery target.

Arq, Inc. (ARQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.

Veritone (VERI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Allegion (ALLE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Heritage Insurance (HRTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.